Valuation Tonix Pharmaceuticals Nasdaq

Stocks

End-of-day quote Nasdaq Other stock markets 2024-02-05			5-day change	1st Jan Change
0.3222 ^USD	-2.36%		+2.32%	-20.05%

07-15	Tonix Pharmaceuticals Advances Tnx-801 Live Attenuated Minimally Replicative Investigational Vaccine Candidate Based on Horsepox Virus to Protect Against Mpox Disease	CI
07-13	Tonix Pharmaceuticals Holding Corp. Announces Major Managed Medicare Agreement for Tonmya and Expands Pharmacy Coverage	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	177.4	22.42	23.62	61.64	193.6	184.3	-	-
Change	-	-87.36%	5.35%	160.94%	214.02%	-4.79%	-	-
Enterprise Value (EV)	177.4	22.42	23.62	61.64	193.6	184.3	184.3	184.3
Change	-	-87.36%	5.35%	160.94%	214.02%	-4.79%	0%	0%
P/E	-1.38x	-0.12x	-0.06x	-0.19x	-1.07x	-1.15x	-1.83x	-5.26x
PBR	-	-	-	-	-	-	-	-
PEG	-	0x	0x	0x	0x	0x	0x	0.1x
Capitalization / Revenue	-	-	3.04x	6.11x	14.8x	5.39x	2.33x	1.13x
EV / Revenue	-	-	0x	0x	0x	5.39x	2.33x	1.13x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-1.07x	-1.2x	-1.94x
EV / FCF	-	-	-	-	-	-0.92x	-0.9x	-1.08x
FCF Yield	-	-	-	-	-	-109%	-111%	-92.3%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-166,400	-65,400	-21,920	-176.6	-14.57	-10.04	-6.3	-2.197
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	7.768	10.09	13.11	34.18	78.93	163
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-92.31	-112.1	-118.4	-136.7	-125.7	-171.7	-153.8	-95.22
Net income ¹	-92.29	-116.9	-116.7	-130	-124	-170	-151.8	-85.5
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	228,928.00	7,796.00	1,289.60	32.98	15.62	11.56	11.56	11.56
Nbr of stocks (in thousands)	0.78	2.88	18.3	1,869	12,392	15,941	-	-
Announcement Date	3/14/22	3/13/23	4/1/24	3/18/25	3/12/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.93x	12.49x	26.13x	0.58%	1,048B
JOHNSON & JOHNSON	26.93x	6.14x	16.82x	2.14%	603B
ABBVIE INC.	33.36x	7.57x	15.52x	2.68%	452B
ROCHE HOLDING AG	17.83x	4.42x	10.88x	3%	327B
NOVARTIS AG	21.97x	5.47x	13.3x	2.81%	283B
ASTRAZENECA PLC	20.86x	4.4x	12.18x	2%	259B
NOVO NORDISK A/S	14.29x	5.31x	10.95x	3.5%	219B
AMGEN INC.	24.02x	6.34x	11.18x	2.75%	198B
GILEAD SCIENCES, INC.	-46.93x	5.62x	31.07x	2.53%	162B
Average	16.36x	6.42x	16.45x	2.44%	394.63B
Weighted average by Cap.	24.13x	7.79x	18.21x	2.01%